- NCT00000680
A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC
Phase 1Completed - NCT00011479
Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents
Phase 1Completed - NCT00008489
Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults
Phase 3Unknown - NCT00008463
A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)
Phase 2Completed - NCT00006591
Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment
Not ApplicableUnknown - NCT00006604
Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents
Phase 1Completed - NCT00001005
A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes
Phase 1Completed - NCT00006444
The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
Completed - NCT00006617
Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
Not ApplicableCompleted - NCT00006490
A Comparison of Two Tests for Anti-HIV Drug Resistance
Completed - NCT00006443
Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection
Not ApplicableCompleted - NCT00006630
Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
Phase 1Withdrawn - NCT00006643
Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus
Completed - NCT00002007
A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia
Not ApplicableCompleted - NCT00001071
A Study of Stem Cells and Filgrastim
Not ApplicableCompleted - NCT00011128
Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment
Phase 3Withdrawn - NCT00011089
Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations
Not ApplicableUnknown - NCT00007202
Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients
Phase 2Completed - NCT00011011
Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV
Phase 1Completed - NCT00006442
The Effects of Anti-HIV Drugs on the HIV Virus in HIV-Infected Patients
Completed - NCT00006440
A Test of Behavioral Intervention for Women at High Risk for HIV Infection
Completed - NCT00007319
Carotid Artery Thickness in HIV Infected and Uninfected Adults
Completed - NCT00007332
Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B
Phase 2Completed - NCT00007423
Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda
Phase 1Completed - NCT00007436
The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients
Phase 3Unknown - NCT00007449
Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors
Phase 2Unknown - NCT00000811
A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
Phase 2Completed - NCT00002220
Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir
Phase 3Completed - NCT00002022
Treatment Program for Anemia in AIDS Patients
Not ApplicableCompleted - NCT00002219
Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children
Phase 2Unknown - NCT00007787
Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
Not ApplicableCompleted - NCT00002006
A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility
Phase 1Completed - NCT00002303
The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic
Not ApplicableCompleted - NCT00002344
A Study of Azithromycin in HIV-Infected Patients
Phase 1Completed - NCT00013663
Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load
Phase 2Completed - NCT00000986
The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex
Phase 1Completed - NCT00002281
A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex
Not ApplicableCompleted - NCT00000825
The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Phase 2Completed - NCT00023244
Steroid Withdrawal in Pediatric Kidney Transplant Recipients
Phase 2Terminated - NCT00002073
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
Not ApplicableCompleted - NCT00002107
A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients
Phase 1Completed - NCT00001128
Treatment of Chronic Cryptosporidiosis in AIDS Patients
Not ApplicableTerminated - NCT00001110
Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients
Not ApplicableCompleted - NCT00001087
The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs
Phase 2Completed - NCT00005012
Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
Phase 2Completed - NCT00000931
HIV Prevention Counseling for Men Who Have Sex With Men
Phase 3Completed - NCT00002379
The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
Phase 2Completed - NCT00002328
Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs
Not ApplicableCompleted - NCT00000873
A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants
Not ApplicableCompleted - NCT00005915
A Comparison of Two Anti-HIV Treatment Plans
Completed - NCT00000899
A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients
Phase 1Completed - NCT00005918
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
Phase 3Completed - NCT00005920
Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole
Phase 2Terminated - NCT00005921
A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis
Not ApplicableCompleted - NCT00005931
SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment
Phase 2Completed - NCT00000892
A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
Not ApplicableCompleted - NCT00000947
A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
Not ApplicableCompleted - NCT00000875
Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection
Not ApplicableTerminated - NCT00006154
A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
Phase 3Completed - NCT00000870
A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
Phase 2Completed - NCT00015704
Effect of Interleukin-2 on HIV Treatment Interruption
Not ApplicableCompleted - NCT00005113
A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
Phase 3Terminated - NCT00000689
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma
Phase 1Completed - NCT00000711
Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC
Phase 1Completed - NCT00000829
A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants
Phase 1Completed - NCT00001079
A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
Phase 2Completed - NCT00005572
A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection
Completed - NCT00000641
A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
Phase 2Completed - NCT00006291
Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination
Phase 2Completed - NCT00000883
Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
Not ApplicableCompleted - NCT00000681
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
Phase 1Completed - NCT00002309
A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients
Not ApplicableCompleted - NCT00000896
A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
Not ApplicableCompleted - NCT00002072
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
Not ApplicableCompleted - NCT00001082
The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients
Phase 3Completed - NCT00006325
Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children
Phase 1Completed - NCT00002070
Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
Phase 3Completed - NCT00002122
A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients
Phase 3Completed - NCT00005758
Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination
Phase 3Completed - NCT00005663
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
Phase 3Unknown - NCT00002085
A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
Not ApplicableCompleted - NCT00002184
A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient
Phase 2Completed - NCT00005762
Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers
Not ApplicableCompleted - NCT00005764
A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients
Phase 4Completed - NCT00005779
Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy
Phase 1Completed - NCT00000820
A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
Phase 2Completed - NCT00005668
A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma
Phase 2Completed - NCT00023192
Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care
Phase 3Completed - NCT00023166
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas
Phase 1Terminated - NCT00023153
Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection
Phase 3Completed - NCT00023114
p450 Mediated Lung Toxicity
Completed - NCT00023101
Lead, Endocrine Disruption and Reproductive Outcomes
Completed - NCT00023140
Collaborative Study of 1,3 Butadiene Biomarkers
Completed - NCT00023127
Reducing Indoor Allergen Exposures in Northern Manhattan and the South Bronx
Not ApplicableCompleted - NCT00023062
Transcranial Magnetic Stimulation in Parkinson's Disease
Completed - NCT00023075
Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
Completed - NCT00023088
Screening Study for the Department of Rehabilitation Medicine
Completed - NCT00023036
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
Completed - NCT00023049
Genetic Analysis of Hereditary Disorders of Hearing and Balance
Completed - NCT00022932
Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP
Phase 2Unknown